TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 105 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $11,529,000 | +2.9% | 1,685,451 | +7.2% | 0.00% | 0.0% |
| Q2 2017 | $11,209,000 | -18.2% | 1,572,026 | +5.5% | 0.00% | 0.0% |
| Q1 2017 | $13,700,000 | +46.2% | 1,490,747 | -35.9% | 0.00% | +50.0% |
| Q4 2016 | $9,373,000 | +6.4% | 2,325,695 | +1.1% | 0.00% | 0.0% |
| Q3 2016 | $8,812,000 | -17.1% | 2,300,705 | -6.9% | 0.00% | -33.3% |
| Q2 2016 | $10,628,000 | +85.0% | 2,471,984 | +99.2% | 0.00% | +50.0% |
| Q1 2016 | $5,745,000 | -88.6% | 1,240,801 | -75.2% | 0.00% | -84.6% |
| Q4 2015 | $50,279,000 | +37.6% | 5,012,815 | +2.4% | 0.01% | +30.0% |
| Q3 2015 | $36,531,000 | -71.0% | 4,896,987 | +84.7% | 0.01% | -68.8% |
| Q2 2015 | $125,769,000 | +43.7% | 2,651,113 | +11.0% | 0.03% | +45.5% |
| Q1 2015 | $87,501,000 | +34.8% | 2,388,136 | +46.1% | 0.02% | +29.4% |
| Q4 2014 | $64,918,000 | +114.8% | 1,634,775 | +7.9% | 0.02% | +112.5% |
| Q3 2014 | $30,227,000 | +45.1% | 1,515,122 | -1.9% | 0.01% | +33.3% |
| Q2 2014 | $20,828,000 | +18.6% | 1,543,916 | -4.3% | 0.01% | +20.0% |
| Q1 2014 | $17,564,000 | -25.8% | 1,612,896 | -7.9% | 0.01% | -28.6% |
| Q4 2013 | $23,673,000 | – | 1,751,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
| Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
| 683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
| Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
| DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
| Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
| A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
| Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
| Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |